The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 301–400 of 1,000
Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist
Li, Q., Liu, W., Gao, S., Mao, Y., & Xin, Y. (2021) · BMC Immunology · doi:10.1186/s12865-021-00401-3 · Cited by 75
“Involvement of IL17A in inflammation and autoimmune disease has been widely illustrated since its discovery on 2005, and abnormal expressions of IL17A are found in development of several diseases including psoriasis, rheumatoid arthritis and multiple sclerosis [4, 5].”
BackgroundLung Epithelial Cells Coordinate Innate Lymphocytes and Immunity against Pulmonary Fungal Infection
Hernández-Santos, N., Wiesner, D. L., Fites, J. S., McDermott, A. J., Warner, T., Wüthrich, M., & Klein, B. S. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.02.011 · Cited by 71
“CD4+IL-17+ (Th17) cells were thought to be the main source of IL-17, but innate sources have now been described (Gaffen et al., 2014): TCRαβ cells, TCRγδ cells, innate lymphoid cells type 3 (ILC3), invariant natural killer T (iNKT) cells, mucosal associated invariant T cells (MAIT) cells (Rahimpour et al.”
BackgroundTargeting Interleukin-23 in the Treatment of Noninfectious Uveitis
Pepple, K. L., & Lin, P. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.05.014 · Cited by 75
Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo
Guendisch, U., Weiss, J., Ecoeur, F., Riker, J., Kaupmann, K., Kallen, J. A., Hintermann, S., Orain, D., Dawson, J., Billich, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188391 · Cited by 75
Molecular Mechanisms of Immune Regulation: A Review
Arneth, B. M. (2025) · Cells · doi:10.3390/cells14040283 · Cited by 77
“IL-23, another vital cytokine involved in immune regulation, has been implicated in T helper 17 (Th17) generation [19] and proliferation [20].”
Jia, Z., Liu, Y., Guan, N., Bo, X., Luo, Z., & Barnes, M. R. (2016) · BMC Genomics · doi:10.1186/s12864-016-2737-8 · Cited by 74
“The chemokine signaling pathway and cytokine-cytokine receptor interaction pathway, including the IL-23 – IL-17 immune axis, play important roles in the pathogenesis of psoriasis and have been targeted by biologic drugs for the treatment of psoriasis with some success [43, 44].”
BackgroundAcute graft-versus-host disease is regulated by an IL-17–sensitive microbiome
Varelias, A., Ormerod, K. L., Bunting, M. D., Koyama, M., Gartlan, K. H., Kuns, R. D., Lachner, N., Locke, K. R., Lim, C. Y., Henden, A. S., et al. (2017) · Blood · doi:10.1182/blood-2016-08-732628 · Cited by 70
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders
Balato, A., Scala, E., Balato, N., Caiazzo, G., Caprio, R. D., Monfrecola, G., Raimondo, A., Lembo, S., & Ayala, F. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1363884 · Cited by 74
“There are evidences that IL-23/IL-17 axis is implicated also in CD pathogenesis [55,99,100].”
BackgroundJiang, Y., Liu, Y., Lu, H., Sun, S.-C., Jin, W., Wang, X., & Dong, C. (2018) · Nature Communications · doi:10.1038/s41467-018-03852-2 · Cited by 67
New therapies for psoriasis and psoriatic arthritis
Ritchlin, C. T., & Krueger, J. G. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000274 · Cited by 73
Lipid metabolism in Th17 cell function
Kanno, T., Nakajima, T., Miyako, K., & Endo, Y. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108411 · Cited by 74
Gestational and lactational exposure to low-dose bisphenol A increases Th17 cells in mice offspring
Luo, S., Li, Y., Li, Y., Zhu, Q., Jiang, J., Wu, C., & Shen, T. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.09.017 · Cited by 74
Visvanathan, S., Baum, P., Vinisko, R., Schmid, R., Flack, M., Lalovic, B. B., Kleiner, O., Fuentes‐Duculan, J., Garcet, S., Davis, J. W., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.042 · Cited by 73
Canavan, T. N., Elmets, C. A., Cantrell, W., Evans, J. M., & Elewski, B. E. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0162-4 · Cited by 72
Leonardi, C. L., Maari, C., Philipp, S., Goldblum, O. M., Zhang, L., Burkhardt, N. Y., Ball, S. G., Mallbris, L., Gonzalez, P., Fernández‐Peñas, P., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.05.032 · Cited by 72
Dewayani, A., Fauzia, K. A., Alfaray, R. I., Waskito, L. A., Doohan, D., Rezkitha, Y. A. A., Abdurachman, A., Kobayashi, T., I’tishom, R., Yamaoka, Y., et al. (2021) · Toxins · doi:10.3390/toxins13050315 · Cited by 72
“IL-23 Macrophage, DCs, neutrophil Promotion to inflammation Maintains Th17 and Th1 proliferation [66,67,90]”
BackgroundCleret‐Buhot, A., Zhang, Y., Planas, D., Goulet, J.-P., Monteiro, P., Gosselin, A., Wacleche, V. S., Tremblay, C. L., Jenabian, M.-A., Routy, J., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0226-9 · Cited by 72
“Similar to GSVA and GO, Gene Set Enrichment Analysis (GSEA) [74] identified top genes linked to canonical pathways (TCR signaling: PAK2, Lck, ZAP-70, CD96), transcription factors (RORC, RUNX1), and biological processes (stress activated protein kinase signaling: MAP4K1, MAP3K4, MAP3K5; protein amino acid dephosphoryla…”
BackgroundAntibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis
Whibley, N., Tritto, E., Traggiai, E., Kolbinger, F., Moulin, P., Brees, D., Coleman, B. M., Mamo, A. J., Garg, A. V., Jaycox, J. R., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0915-428r · Cited by 65
“The IL-17 cytokine family has unique structural and functional features [28, 29] (Fig.”
BackgroundSelf-citationIL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation
Krohn, S., Nies, J. F., Kapffer, S., Schmidt, T., Riedel, J.-H., Kaffke, A., Peters, A., Borchers, A., Steinmetz, O. M., Krebs, C. F., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017090949 · Cited by 70
T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities
Casciano, F., Pigatto, P. D. M., Secchiero, P., Gambari, R., & Reali, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01390 · Cited by 72
Cellular Signaling Pathways in Medium and Large Vessel Vasculitis
Watanabe, R., Berry, G. J., Liang, D. H., Goronzy, J. J., & Weyand, C. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587089 · Cited by 71
Saran, A., Nishizaki, D., Lippman, S. M., Kato, S., & Kurzrock, R. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.01.002 · Cited by 71
Mancini, F., Monaci, E., Lofano, G., Torre, A., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Galletti, B., Laera, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147767 · Cited by 71
Qie, C., Jiang, J., Liu, W., Hu, X., Chen, W., Xie, X., & Liu, J. (2020) · Theranostics · doi:10.7150/thno.45614 · Cited by 71
“A sole application of IMQ rapidly induces dermatitis closely resembling human psoriasis [13-15].”
BackgroundMucosal immunity to poliovirus
Connor, R. I., Brickley, E. B., Wieland‐Alter, W., Ackerman, M. E., Weiner, J. A., Modlin, J. F., Bandyopadhyay, A. S., & Wright, P. F. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00428-0 · Cited by 72
The role of Th17 cells in viral infections
Aghbash, P. S., Hemmat, N., Nahand, J. S., Shamekh, A., Memar, M. Y., Babaei, A., & Baghi, H. B. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107331 · Cited by 70
Olsson, R. I., Xue, Y., von Berg, S., Aagaard, A., McPheat, J., Hansson, E. L., Bernström, J., Hansson, P., Jirholt, J., Grindebacke, H., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500432 · Cited by 70
Alves, C. H., Farrell, E., Vis, M., Colin, E. M., & Lubberts, E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8522-7 · Cited by 71
“guselkumab) have been performed in patients with psoriasis, ankylosing spondylitis and psoriatic arthritis [168].”
BackgroundThe IL-12 cytokine family in cardiovascular diseases
van der Heijden, T., Bot, I., & Kuiper, J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.10.010 · Cited by 70
Alesa, D. I., Alshamrani, H. M., Alzahrani, Y. A., Alamssi, D., Alzahrani, N., & Almohammadi, M. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_709_19 · Cited by 70
RetractedInflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
Fieldhouse, K. A., Ukaibe, S., Crowley, E. L., Khanna, R., O’Toole, A., & Gooderham, M. (2020) · Drugs in Context · doi:10.7573/dic.2020-2-1 · Cited by 70
Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice
Chen, L., Deshpande, M., Grisotto, M. A. G., Smaldini, P., Garcia, R., He, Z., Gulko, P. S., Lira, S. A., & Furtado, G. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-65269-6 · Cited by 70
The Roles of Lipoprotein in Psoriasis
Shih, C., Chen, C.-C., Chu, C.-K., Wang, K.-H., Huang, C., & Lee, A.-W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030859 · Cited by 69
“Notably, although IL-17 is a signature cytokine of TH17 cells, other innate and acquired immune cells also produce IL-17, including CD8+ T cells, γδ T cells, innate lymphoid cells, and natural killer (NK) T cells [32].”
BackgroundWu, S., Xu, Y., Yang, L., Guo, L., & Jiang, X. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1294416 · Cited by 69
“Therefore, inhibition of IL-23 blocks downstream production of IL-17A by Th17 cells and other cell types (87).”
BackgroundVillegas, J. A., Wassenhove, J. V., Panse, R. L., Berrih‐Aknin, S., & Dragin, N. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13591 · Cited by 69
Walch‐Rückheim, B., Ströder, R., Theobald, L., Pahne‐Zeppenfeld, J., Hegde, S., Kim, Y.-J., Bohle, R. M., Juhasz‐Böss, I., Solomayer, E., & Smola, S. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1913 · Cited by 69
T helper cells in leprosy: An update
Saini, C., Tarique, M., Rai, R., Siddiqui, A., Khanna, N., & Sharma, A. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.013 · Cited by 68
Mimpen, J. Y., Baldwin, M. J., Cribbs, A. P., Philpott, M., Carr, A. J., Dakin, S. G., & Snelling, S. J. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676173 · Cited by 69
He, Z., Ma, J., Wang, R., Zhang, J., Huang, Z., Wang, F., Sen, S., Rothenberg, E. V., & Sun, Z. (2017) · Nature Immunology · doi:10.1038/ni.3832 · Cited by 68
Interleukin-17: Friend or foe in organ fibrosis
Ramani, K., & Biswas, P. S. (2019) · Cytokine · doi:10.1016/j.cyto.2018.11.003 · Cited by 66
“The IL-17R family has five receptor subunits, IL-17RA-IL-17RE and shows significant similarities in the structure of their receptor heterodimers [22].”
BackgroundInfluentialIL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation
Li, H., Tsokos, M., Bhargava, R., Adamopoulos, I. E., Menn‐Josephy, H., Stillman, I. E., Rosenstiel, P. C., Jordan, J. L., & Tsokos, G. C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142428 · Cited by 69
“1172/ JCI142428DS1) affirmed the hypothesis that the IL-23/IL-17 axis contributes to the pathogenesis of various types of nephritis (7, 23, 32); however, it remains unknown whether these cytokines could act on resident kidney cells directly.”
BackgroundThe Yin and Yang of IL-17 in Systemic Sclerosis
Wei, L., Abraham, D., & Ong, V. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.885609 · Cited by 67
“For instance, IL-17A could induce in target cells the expression of neutrophil chemoattractants such as CXCL1, CXCL2, CXCL5, and CXCL8; CCL20 is expressed stronger under IL-17A stimulation which promotes the recruitment of lymphocytes; growth factors such as G-CSF and GM-CSF are upregulated as well (2, 6, 11).”
BackgroundXin, L., Zhang, H., Zhang, R., Li, H., Wang, W., Wang, L., Wang, H., Qiu, L., & Song, L. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.08.002 · Cited by 67
Levitová, A., Hulejová, H., Špiritović, M., Pavelká, K., Šenolt, L., & Hušáková, M. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1180-1 · Cited by 67
Li, X., Anderson, M. D., Collin, D., Muegge, I., Wan, J., Brennan, D. L., Kugler, S. Z., Terenzio, D., Kennedy, C., Lin, S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.789024 · Cited by 67
“ROR t is also required for the production of IL-17 from other cell types, including T cells, invariant natural killer T cells, and group 3 innate lymphoid cells, and is necessary for Th17 cells to produce other proinflammatory cytokines such as IL-22, GM-CSF, and the IL-23R (19).”
BackgroundIL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis
Zhang, P., Liu, J., Lee, A. A., Tsaur, I., Ohira, M., Duong, V., Vo, N., Watari, K., Su, H., Kim, J. Y., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.08.012 · Cited by 66
Plasma and cerebrospinal fluid inflammatory cytokines in perinatal depression
Miller, E. S., Sakowicz, A., Roy, A., Yang, A., Sullivan, J. T., Grobman, W. A., & Wisner, K. L. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.12.015 · Cited by 66
Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases
Goff, B. L., Bouvard, B., Lequerré, T., Lespessailles, É., Marotte, H., Pers, Y., & Cortet, B. (2019) · Mediators of Inflammation · doi:10.1155/2019/8659302 · Cited by 66
“Polarization of CD4 naïve cells towards Th17 cells under the influence of IL-23, but also TGFβ and IL-6, has been shown to play an important role in several inflammatory diseases [9, 10].”
BackgroundInterleukin 35 Regulatory B Cells
Choi, J. K., & Egwuagu, C. E. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.07.019 · Cited by 66
Targeting IL-17 in autoimmunity and inflammation
Kim, B. S., Park, Y.-J., & Chung, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0823-8 · Cited by 66
Mo, C., Zeng, Z., Deng, Q., Ding, Y. P., & Xiao, R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.037 · Cited by 65
Deenonpoe, R., Prayong, P., Thippamom, N., Meephansan, J., & Na‐Bangchang, K. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2535-3 · Cited by 65
“Interleukin (IL)-23/Th17 cell axis plays a crucial role in the pathogenesis of psoriasis [4, 5].”
BackgroundMicrobiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer
Bellone, M., Brevi, A., & Huber, S. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-19 · Cited by 65
“While monoclonal antibodies blocking the IL-17–IL-23 immune axis are already available in the clinic (13), they are not devoid of”
BackgroundInfluentialSpondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics
Bridgewood, C., Watad, ., Cuthbert, R. J., & McGonagle, D. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000529 · Cited by 64
Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances
Shao, S., Wang, G., Maverakis, E., & Gudjonsson, J. E. (2020) · Drugs · doi:10.1007/s40265-020-01283-2 · Cited by 64
Conti, H. R., Whibley, N., Coleman, B. M., Garg, A. V., Jaycox, J. R., & Gaffen, S. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122807 · Cited by 57
“The IL-17 cytokine family consists of six related members: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (IL-25) and IL-17F [17, 18].”
InfluentialSelf-citationAnti-interleukin-23 agents for the treatment of ulcerative colitis
Hanžel, J., & D’Haens, G. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1697227 · Cited by 64
Modeling Rheumatoid Arthritis In Vitro: From Experimental Feasibility to Physiological Proximity
Damerau, A., & Gaber, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217916 · Cited by 64
Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet’s disease
Ahn, Y., Hwang, J., Zheng, Z., Bang, D., & Kim, D. Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-03251-5 · Cited by 63
Role of Interleukin-17 in Acute Pancreatitis
Li, G., Chen, H., Liu, L., Xiao, P., Xie, Y., Geng, X., Zhang, T., Zhang, Y., Lu, T., Tan, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674803 · Cited by 63
Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome
Li, Y., Liu, Y., & Chu, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/638470 · Cited by 63
“The discovery of Th17 subset not only changes the classical Th1/Th2 paradigm in T cell immune responses, but also provides uswith new insights into the pathophysiological process in several autoimmune diseases [3].”
BackgroundBose, T., Diedrichs‐Möhring, M., & Wildner, G. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.001 · Cited by 63
Zhang, H., Huang, E., Kahwaji, J. M., Nast, C. C., Li, P., Mirocha, J., Thomas, D. L., Ge, S., Vo, A. A., Jordan, S. C., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001834 · Cited by 63
Updates on T helper type 17 immunity in respiratory disease
Iwanaga, N., & Kolls, J. K. (2018) · Immunology · doi:10.1111/imm.13006 · Cited by 63
Villegas, J. A., Bayer, A. C., Ider, K., Bismuth, J., Truffault, F., Roussin, R., Santelmo, N., Panse, R. L., Berrih‐Aknin, S., & Dragin, N. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.005 · Cited by 63
Sun, R., Hedl, M., & Abraham, C. (2019) · Gut · doi:10.1136/gutjnl-2018-316830 · Cited by 63
T Helper 17 Cells as Pathogenic Drivers of Periodontitis
Dutzan, N., & Abusleme, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-28524-1_9 · Cited by 63
Mikami, Y., Philips, R. L., Sciumè, G., Petermann, F., Meylan, F., Nagashima, H., Yao, C., Davis, F. P., Brooks, S. R., Sun, H., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.02.015 · Cited by 64
“In particular, the degree to which inflammatory signature manifests is relevant to understanding the physiology of intestinal mucosal immunity at healthy steady state as well as pathological autoimmune conditions (Gaffen et al., 2014; Patel and Kuchroo, 2015; Stockinger and Omenetti, 2017).”
BackgroundThe Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
Paroli, M., Caccavale, R., Fiorillo, M. T., Spadea, L., Gumina, S., Candela, V., & Paroli, M. P. (2022) · Pathogens · doi:10.3390/pathogens11121547 · Cited by 62
“However, subsequent study showed that other soluble factors involved in the inflammatory response, such as IL-17F, IL-21, IL-22, IL-26, and the chemokines CXCL8 and CCL20, were also produced [5].”
BackgroundFerreira, L. S., Gonçalves, A. C., Portuondo, D. L., Maia, D. C. G., Placeres, M. C. P., Batista-Duharte, A., & Carlos, I. Z. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.02.009 · Cited by 62
Koudstaal, T., Boomars, K. A., & Kool, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020561 · Cited by 62
“Th cells are known to play an important role in many inflammatory and autoimmune diseases [77].”
BackgroundNoncanonical STAT3 activity sustains pathogenic Th17 proliferation and cytokine response to antigen
Poholek, C. H., Raphael, I., Wu, D., Revu, S. K., Rittenhouse, N., Uche, U. N., Majumder, S., Kane, L., Poholek, A. C., & McGeachy, M. J. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191761 · Cited by 62
Interleukin-23 receptor signaling impairs the stability and function of colonic regulatory T cells
Jacobse, J., Brown, R. E., Li, J., Pilat, J. M., Pham, L., Short, S. P., Peek, C. T., Rolong, A., Washington, M. K., Martínez‐Barricarte, R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112128 · Cited by 61
“10 Yet , inhibition of IL-17A or IL-17R using monoclonal antibodies (i.e., secukinumab, AMG827) failed to improve CD in clinical trials and even worsened disease.”
A Cardiolipin from Muribaculum intestinale Induces Antigen-Specific Cytokine Responses
Bang, S., Shin, Y., Ma, X., Park, S., Graham, D. B., Xavier, R. J., & Clardy, J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09734 · Cited by 61
“27 An additional and completely unexpected feature of MiCL-1 is its similarity to a recently characterized immunomodulatory metabolite from Streptococcus pyogenes .”
BackgroundTLR3 drives IRF6‐dependent IL‐23p19 expression and p19/EBI3 heterodimer formation in keratinocytes
Ramnath, D., Tunny, K. A., Hohenhaus, D. M., Pitts, C. M., Bergot, A., Hogarth, P. M., Hamilton, J. A., Kapétanovic, R., Sturm, R. A., Scholz, G. M., et al. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.77 · Cited by 61
Pro-inflammatory cytokines in cryptoglandular anal fistulas
van Onkelen, R. S., Gosselink, M. P., van Meurs, M., Melief, M., Schouten, W. R., & Laman, J. D. (2016) · Techniques in Coloproctology · doi:10.1007/s10151-016-1494-7 · Cited by 61
Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway
Bissonnette, R., Fuentes‐Duculan, J., Mashiko, S., Li, X., Bonifacio, K. M., Cueto, I., Suárez‐Fariñas, M., Maari, C., Bolduc, C., Nigen, S., et al. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.09.019 · Cited by 62
Tamassia, N., Arruda-Silva, F., Calzetti, F., Lonardi, S., Gasperini, S., Gardiman, E., Bianchetto-Aguilera, F. M., Gatta, L. B., Girolomoni, G., Mantovani, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00795 · Cited by 63
Page, K. M., Suárez‐Fariñas, M., Suprun, M., Zhang, W., Garcet, S., Fuentes‐Duculan, J., Li, X., Scaramozza, M., Kieras, E., Banfield, C. R., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.11.027 · Cited by 61
Probiotics in the Therapeutic Arsenal of Dermatologists
Navarro-López, V., Núñez-Delegido, E., Ruzafa-Costas, B., Sánchez-Pellicer, P., Agüera-Santos, J., & Navarro-Moratalla, L. (2021) · Microorganisms · doi:10.3390/microorganisms9071513 · Cited by 54
“In these cases, drugs have been developed immune-modulators as anti -TNF and anti-IL-23 monoclonal antibodies, among others [45].”
BackgroundLi, Y., Liu, N., Ge, Y., Yang, Y., Ren, F., & Wu, Z. (2022) · European Journal of Immunology · doi:10.1002/eji.202149401 · Cited by 60
IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases
Riedel, J.-H., Paust, H., Krohn, S., Turner, J., Kluger, M. A., Steinmetz, O. M., Krebs, C. F., Stahl, R. A. K., & Panzer, U. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015101077 · Cited by 60
Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma
Liljevald, M., Rehnberg, M., Söderberg, M. P., Ramnegård, M., Börjesson, J., Luciani, D., Krutrök, N., Brändén, L., Johansson, C., Xu, X., et al. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.036 · Cited by 60
Segueni, N., Tritto, E., Bourigault, M.-L., Rose, S., Erard, F., Bert, M. L., Jacobs, M., Padova, F. D., Stiehl, D. P., Moulin, P., et al. (2016) · Scientific Reports · doi:10.1038/srep36923 · Cited by 61
Wang, H., Zhong, D., Chen, H., Jin, J., Liu, Q., & Li, G. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.031 · Cited by 60
B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis
Wilbrink, R., Spoorenberg, A. J. P. L., Verstappen, G. M. P. J., & Kroese, F. G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413325 · Cited by 61
“As mentioned previously, potent sources of IL-17 are innate immune cells and T cells [153].”
BackgroundCandida albicans at Host Barrier Sites: Pattern Recognition Receptors and Beyond
Swidergall, M. (2019) · Pathogens · doi:10.3390/pathogens8010040 · Cited by 59
“IL-17/22-producing ILC3s and Th17 cells regulate defense peptide and IgA expression [117,118].”
BackgroundTissue-resident memory Th17 cells maintain stable fungal commensalism in the oral mucosa
Kirchner, F. R., & LeibundGut-Landmann, S. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-0327-1 · Cited by 59
The role of IL‐23 and the use of IL‐23 inhibitors in psoriatic arthritis
Fragoulis, G., & Siebert, S. (2022) · Musculoskeletal Care · doi:10.1002/msc.1694 · Cited by 60
“The main homoeostatic role of the IL‐23/IL‐17 pathway appears to be host defence against fungal and bacterial pathogens at mucosal barriers, as well as regulating barrier function (Gaffen et al., 2014).”
BackgroundEgwuagu, C. E., & Yu, C. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2015012558 · Cited by 59
Espígol‐Frigolé, G., Planas‐Rigol, E., Ohnuki, H., Salvucci, O., Kwak, H., Ravichandran, S., Luke, B. T., Cid, M. C., & Tosato, G. (2016) · Science Signaling · doi:10.1126/scisignal.aad2357 · Cited by 61
“ww tide (also known as the IL-12b chain) (7), promotes the development of a population of T helper (TH) cells, designated TH17 cells because they produce IL-17, which are implicated in Crohn’s disease, rheumatoid arthritis, psoriasis, and other immune-mediated inflammatory diseases (8).”
BackgroundMicrobiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease
Wu, W. H., Chen, F., Liu, Z., & Cong, Y. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000775 · Cited by 59
“expression of lineage-specific transcriptional regulator RORgt, eventually leading to Th17 phenotype.(32) It is clear now that Th17-cell differentiation involves several stages.”
BackgroundKurschus, F. C., & Moos, S. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.010 · Cited by 60
Interleukin 17A in atherosclerosis – Regulation and pathophysiologic effector function
Nordlohne, J., & von Vietinghoff, S. (2017) · Cytokine · doi:10.1016/j.cyto.2017.06.016 · Cited by 61
“muscle cells, pericytes, macrophages, and T cells [5,11,12].”
BackgroundHuo, W., Liu, Y., Lei, Y., Zhang, Y., Huang, Y., Mao, Y., Wang, C., Sun, Y., Zhang, W., Ma, Z., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.024 · Cited by 59
Bridgewood, C., Newton, D. J., Bragazzi, N. L., Wittmann, M., & McGonagle, D. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101520 · Cited by 59
Bimekizumab for the Treatment of Psoriasis
Freitas, E., Blauvelt, A., & Torres, T. R. (2021) · Drugs · doi:10.1007/s40265-021-01612-z · Cited by 58
“These cells are under the regulatory control of IL-23, producing cytokines of the IL-17 family [13, 14].”
BackgroundVitamin B5 rewires Th17 cell metabolism via impeding PKM2 nuclear translocation
Chen, C., Zhang, W., Zhou, T., Liu, Q., Han, C., Huang, Z., Chen, S., Mei, Q., Zhang, C., Zhang, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111741 · Cited by 58
Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis
Egozi, A., Olaloye, O. O., Werner, L., Silva, T., McCourt, B. T., Pierce, R. W., An, X., Wang, F., Chen, K., Pober, J. S., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002124 · Cited by 58
“…immune side, consistent with previous work that implicated Th17 T cells in the pathogenesis of NEC [30,31,53], we observed an up-regulation of genes classically expressed by Th17 cells ( BATF and CCL20 [54,55]) and additionally identified increased cytotoxic activity in NEC-activated T cells.”
Epithelial-derived interleukin-23 promotes oral mucosal immunopathology
Kim, T. S., Ikeuchi, T., Theofilou, V. I., Williams, D. W., Greenwell‐Wild, T., June, A., Adade, E. E., Li, L., Abusleme, L., Dutzan, N., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.020 · Cited by 58
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.